Literature DB >> 20877178

Microcirculatory alterations in the critically ill.

Jean-Louis Vincent1, Daniel De Backer.   

Abstract

Disturbed regional oxygenation is believed to contribute to organ dysfunction, organ failure, and death. Recent techniques such as orthogonal polarization spectral/sidestream darkfield imaging and near infrared spectroscopy have provided insight into the microcirculatory alterations present in critically ill patients. Using these techniques, persistent microcirculatory alterations have been shown to be associated with a worse prognosis, notably in patients with septic shock, irrespective of systemic hemodynamic variables. Data on the effects of therapeutic interventions on the microcirculation are also being gathered and may help in developing strategies that can influence regional oxygenation and cellular metabolism, and thereby prevent or reverse organ failure. Whether monitoring the microcirculation can be used to guide therapy remains unclear and requires further study, and this is an exciting field of ongoing research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20877178     DOI: 10.3810/hp.2009.12.262

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  3 in total

1.  Small-volume resuscitation from hemorrhagic shock with polymerized human serum albumin.

Authors:  Catalina Messmer; Ozlem Yalcin; Andre F Palmer; Pedro Cabrales
Journal:  Am J Emerg Med       Date:  2011-11-17       Impact factor: 2.469

2.  Sidestream dark field images of the microcirculation: intra-observer reliability and correlation between two semi-quantitative methods for determining flow.

Authors:  Sandra M Petersen; Gorm Greisen; Simon Hyttel-Sorensen; Gitte H Hahn
Journal:  BMC Med Imaging       Date:  2014-05-06       Impact factor: 1.930

3.  Videomicroscopy as a tool for investigation of the microcirculation in the newborn.

Authors:  Ian M R Wright; Joanna L Latter; Rebecca M Dyson; Chris R Levi; Vicki L Clifton
Journal:  Physiol Rep       Date:  2016-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.